High Co-Expression of PDCD1/TIGIT/CD47/KIR3DL2 in Bone Marrow Is Associated with Poor Prognosis for Patients with Myelodysplastic Syndrome.

J Oncol · 2023 · PMC9931467 · PMID 36816361

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

As shown in Figure 3 , there was a clear trend suggesting that high expression of PDCD1 or TIGIT is associated with poor OS for MDS patients younger than 60 years of age, although the P value of TIGIT is not statistically significant ( PDCD1 : HR = 7.09, P = 0.025; TIGIT : HR > 100, P = 0.070).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

High Co-Expression of <i>PDCD1</i>/<i>TIGIT</i>/<i>CD47</i>/<i>KIR3DL2</i> in Bone Marrow Is Associated with Poor Prognosis for Patients with Myelodysplastic Syndrome.

The sentences